On May 8, 2008 Public Citizen's Health Research Group (HRG) sent its "Petition to the FDA to Ban Ortho-Evra" to Commissioner Andrew von Eschenbach. In this 11-page letter, Sidney Wolfe, M.D., the Dir...
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Genzyme Corp. (NASDAQ: GENZ) reported today that a preliminary analysis of data from an ongoing open-label Phase 2 clinical trial of its investigational oral therapy Genz-112638 showed that the compo
read more »
Add this link to...
Bury
Add to:
| Bookmarks
14th-15th May, 2008, Amsterdam
Jacob Fleming's 4th Annual Enhancing Clinical Trial Processes conference will provide the answers to your questions. Industry experts will present real life case stud
read more »
Add this link to...
Bury
Add to:
| Bookmarks
With the launch of its first call for proposals, the Innovative Medicines Initiative (IMI) got underway on 30 April. Joining forces, the European Commission and the European Federation of Pharmaceuti
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Bayer Schering Pharma's new low-dose oral contraceptive YAZ® has been approved in the EU. YAZ® will be the first oral contraceptive on the European market containing the unique progestin drospirenon
read more »
Add this link to...
Bury
Add to:
| Bookmarks
Boehringer Ingelheim announced that the European Commission has given the full marketing authorisation to its HIV protease inhibitor (PI), Aptivus® (tipranavir). The Commission has fully approved Apt
read more »
Add this link to...
Bury
Add to:
| Bookmarks
A team of researchers from Novo Nordisk is nominated for Europe's top innovation prize, Inventor of the Year 2008 Award, that will be presented at a ceremony in Ljubljana, Slovenia, on 6 May by the
read more »
Add this link to...
Bury
Add to:
| Bookmarks
GlaxoSmithKline plc (GSK) announced that Fountain Acquisition Corporation, a wholly-owned subsidiary of GSK, is commencing a cash tender offer to purchase all outstanding shares of common stock of Si
read more »
Add this link to...
Bury
Add to:
| Bookmarks